News Opthea Limited

Equities

OPT

AU000000OPT2

Market Closed - Australian S.E. Other stock markets 02:10:23 2024-05-29 am EDT			5-day change	1st Jan Change
0.55 ^AUD	-6.78%		-14.06%	-3.51%

May. 28	Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD	CI
May. 28	Opthea Completes Enrollments in COAST, ShORe Trials	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD	May. 28	AQ
Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD	May. 28	CI
Opthea Completes Enrollments in COAST, ShORe Trials	May. 27	MT
Opthea Announces Upcoming Presentations at the Retina World Congress 2024	May. 01	AQ
Opthea : Quarterly Activity Report - Form 6-K	Apr. 30	PU
Opthea to Present at the OIS Retina Innovation Summit at ARVO	Apr. 25	AQ
Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K	Apr. 25	PU
Opthea Appoints John Han, PharmD, as VP Medical Affairs	Apr. 08	AQ
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference	Apr. 04	AQ
Opthea Appoints Sujal Shah to the Board of Directors	Apr. 03	AQ
Opthea Limited Announces Board Changes	Apr. 03	CI
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024	Mar. 19	AQ
Opthea to Participate in the Leerink Partners Global Biopharma Conference	Mar. 05	AQ
Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump	Feb. 28	MT
Opthea Reports Half-Year Financial Results and Business Updates	Feb. 28	AQ
Opthea Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Opthea Appoints Chief Medical Advisor; Shares Decline 4%	Feb. 19	MT
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor	Feb. 19	AQ
Opthea Appoints Arshad M. Khanani as Chief Medical Advisor	Feb. 19	CI
Opthea Concludes Enrollment in Inaugural Wet AMD Drug Trial	Feb. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Opthea Limited

Equities

OPT

AU000000OPT2

Summary

Filters